{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T23:07:43Z","timestamp":1772060863893,"version":"3.50.1"},"reference-count":29,"publisher":"MDPI AG","issue":"13","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Background: Invasive fungal infections (IFIs) after liver transplantation (LT) remain a concern. No universal protocol for antifungal prophylaxis in LT exists. Antifungal prophylaxis varies across European centers. Studies suggest risk stratification for prophylaxis. This study assessed IFI frequency and outcomes in adult LT recipients without antifungal prophylaxis and evaluated risk stratification for predicting IFIs. Method: A retrospective analysis of clinical and microbiological data from 244 liver transplant patients focused on IFI within 100 days post-transplantation. Of these, 225 (92%) had right liver transplants from living donors. We assessed two risk stratification models for predicting IFI: one categorizes patients into low- and high-risk groups, and the other divides patients into three categories, with two eligible for prophylaxis and one not. Results: Of 244 patients, 3% (seven individuals) developed invasive fungal infections (IFI), including two aspergillosis and five candidiasis. IFI occurred in 8% of high-risk and 2% of low-risk patients in the first stratification, with no significant difference between groups (p = 0.144). In the second stratification, IFI was found in 4% of the target and 2% of non-target groups, without a significant difference (p = 0.455). Patients with IFI showed higher mean MELD scores of 21.71 \u00b1 2.35 versus 17.04 \u00b1 6.48 in those without IFI (p &lt; 0.05). Conclusions: This study evaluated IFI outcomes without systemic antifungal prophylaxis in LT recipients. Limited antifungal use in a major living liver donor transplantation (LDLT) group, with low MELD scores and immunosuppression protocols, could be feasible. Future multicenter studies can improve understanding and develop prophylaxis algorithms for LT settings.<\/jats:p>","DOI":"10.3390\/jcm14134663","type":"journal-article","created":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T07:42:06Z","timestamp":1751355726000},"page":"4663","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Liver Transplantation Without Systemic Antifungal Prophylaxis\u2014An Exceptional Perspective from a Single Center Experience"],"prefix":"10.3390","volume":"14","author":[{"given":"Kenan","family":"Moral","sequence":"first","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Gazi University, Ankara 06560, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2099-9697","authenticated-orcid":false,"given":"G\u00f6khan","family":"Kaba\u00e7am","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Liver Transplantation, G\u00fcven Hospital, Ankara 06540, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muzaffer","family":"Atl\u0131","sequence":"additional","affiliation":[{"name":"Department of General Surgery, G\u00fcven Hospital, Ankara 06540, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehmet","family":"Cindoruk","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Gazi University, Ankara 06560, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ya\u015far","family":"Bay\u0131nd\u0131r","sequence":"additional","affiliation":[{"name":"Department of Infectious Disease and Clinical Microbiology, G\u00fcven Hospital, Ankara 06540, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ye\u015fim","family":"Sardan","sequence":"additional","affiliation":[{"name":"Department of Infectious Disease and Clinical Microbiology, G\u00fcven Hospital, Ankara 06540, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sedat","family":"Karademir","sequence":"additional","affiliation":[{"name":"Department of General Surgery, G\u00fcven Hospital, Ankara 06540, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2025,7,1]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1111\/j.1432-2277.2009.00974.x","article-title":"Antimicrobial prophylaxis in liver transplant patients\u2014A multicenter survey endorsed by the European Liver and Intestine Transplant Association","volume":"23","author":"Vandecasteele","year":"2010","journal-title":"Transpl. Int."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Breitkopf, R., Treml, B., Simmet, K., Bukumiri\u0107, Z., Fodor, M., Senoner, T., and Rajsic, S. (2023). Incidence of Invasive Fungal Infections in Liver Transplant Recipients under Targeted Echinocandin Prophylaxis. J. Clin. Med., 12.","DOI":"10.3390\/jcm12041520"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"2765","DOI":"10.1111\/ajt.12925","article-title":"Antifungal prophylaxis in liver transplantation: A systematic review and network meta-analysis","volume":"14","author":"Evans","year":"2014","journal-title":"Am. J. Transplant."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Senoner, T., Breitkopf, R., Treml, B., and Rajsic, S. (2023). Invasive Fungal Infections after Liver Transplantation. J. Clin. Med., 12.","DOI":"10.3390\/jcm12093238"},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Scolarici, M., Jorgenson, M., Saddler, C., and Smith, J. (2021). Fungal Infections in Liver Transplant Recipients. J. Fungi, 7.","DOI":"10.3390\/jof7070524"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.4254\/wjh.v13.i11.1653","article-title":"Fungal infections following liver transplantation","volume":"13","author":"Khalid","year":"2021","journal-title":"World J. Hepatol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1086\/596757","article-title":"Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America","volume":"48","author":"Pappas","year":"2009","journal-title":"Clin. Infect. Dis."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1111\/j.1600-6143.2005.01176.x","article-title":"Invasive fungal infections in low-risk liver transplant recipients: A multi-center prospective observational study","volume":"6","author":"Pappas","year":"2006","journal-title":"Am. J. Transplant."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/ajt.12993","article-title":"Targeted versus universal antifungal prophylaxis among liver transplant recipients","volume":"15","author":"Eschenauer","year":"2015","journal-title":"Am. J. Transplant."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1007\/BF00191586","article-title":"Fungal infections in liver transplant recipients","volume":"379","author":"Grauhan","year":"1994","journal-title":"Langenbecks Arch. Chir."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.2147\/DDDT.S100795","article-title":"Efficacy of nystatin for the treatment of oral candidiasis: A systematic review and meta-analysis","volume":"10","author":"Lyu","year":"2016","journal-title":"Drug Des. Devel Ther."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"S77","DOI":"10.1093\/cid\/ciaa1765","article-title":"The Evidence Supporting the Revised EORTC\/MSGERC Definitions for Invasive Fungal Infections","volume":"72","author":"Pappas","year":"2021","journal-title":"Clin. Infect. Dis."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1001\/archsurg.1991.01410260033005","article-title":"Clinical spectrum of fungal infections after orthotopic liver transplantation","volume":"126","author":"Castaldo","year":"1991","journal-title":"Arch. Surg."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1002\/lt.21826","article-title":"Antifungal prophylaxis in liver transplant recipients","volume":"15","author":"Eschenauer","year":"2009","journal-title":"Liver Transpl."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"e13623","DOI":"10.1111\/ctr.13623","article-title":"Candida infections in solid organ transplantation: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice","volume":"33","author":"Aslam","year":"2019","journal-title":"Clin. Transplant."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"E454","DOI":"10.1111\/ctr.12129","article-title":"Fungal infections after liver transplantation: Outcomes and risk factors revisited in the MELD era","volume":"27","author":"Saliba","year":"2013","journal-title":"Clin. Transplant."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1097\/00007890-199610150-00010","article-title":"Risk factors of invasive Candida and non-Candida fungal infections after liver transplantation","volume":"62","author":"Patel","year":"1996","journal-title":"Transplantation"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/BF00158579","article-title":"Surveillance and treatment of liver transplant recipients for candidiasis and aspergillosis","volume":"8","author":"Viviani","year":"1992","journal-title":"Eur. J. Epidemiol."},{"key":"ref_19","first-page":"38","article-title":"Fungal infections complicating orthotopic liver transplantation","volume":"106","author":"Karchmer","year":"1995","journal-title":"Trans. Am. Clin. Climatol. Assoc."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1093\/infdis\/170.3.644","article-title":"Risk factors for invasive fungal infections complicating orthotopic liver transplantation","volume":"170","author":"Collins","year":"1994","journal-title":"J. Infect. Dis."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/00007890-200201150-00011","article-title":"Trends in invasive fungal infections in liver transplant recipients: Correlation with evolution in transplantation practices","volume":"73","author":"Singh","year":"2002","journal-title":"Transplantation"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"e13361","DOI":"10.1111\/tid.13361","article-title":"Epidemiology and risk factors for invasive fungal disease in liver transplant recipients in a tertiary transplant center","volume":"22","author":"Lum","year":"2020","journal-title":"Transpl. Infect. Dis."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1159\/000486548","article-title":"Risk Analysis for Invasive Fungal Infection after Living Donor Liver Transplantation: Which Patient Needs Potent Prophylaxis?","volume":"36","author":"Utsumi","year":"2019","journal-title":"Dig. Surg."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1136\/ejhpharm-2020-002385","article-title":"Effects of antifungal drugs on the plasma concentrations and dosage of tacrolimus in kidney transplant patients","volume":"29","author":"Cheng","year":"2022","journal-title":"Eur. J. Hosp. Pharm."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1034\/j.1399-3062.2001.003003128.x","article-title":"Infectious complications of lung transplantation","volume":"3","author":"Alexander","year":"2001","journal-title":"Transpl. Infect. Dis."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1055\/s-2008-1063851","article-title":"Rare and emerging fungal pulmonary infections","volume":"29","author":"Varkey","year":"2008","journal-title":"Semin. Respir. Crit. Care Med."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1097\/01.cco.0000152975.65477.7c","article-title":"The changing face of invasive fungal infections in hematopoietic cell transplant recipients","volume":"17","author":"Wingard","year":"2005","journal-title":"Curr. Opin. Oncol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1111\/j.1432-2277.2002.tb00176.x","article-title":"Antifungal prophylaxis in liver transplant recipients: A randomized placebo-controlled study","volume":"15","author":"Biancofiore","year":"2002","journal-title":"Transpl. Int."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1093\/jac\/dkg450","article-title":"Prevention of invasive fungal infections in liver transplant recipients: The role of prophylaxis with lipid formulations of amphotericin B in high-risk patients","volume":"52","author":"Moreno","year":"2003","journal-title":"J. Antimicrob. Chemother."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/14\/13\/4663\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:02:27Z","timestamp":1760032947000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/14\/13\/4663"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,1]]},"references-count":29,"journal-issue":{"issue":"13","published-online":{"date-parts":[[2025,7]]}},"alternative-id":["jcm14134663"],"URL":"https:\/\/doi.org\/10.3390\/jcm14134663","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,1]]}}}